Drug Profile
Bupivacaine buccal - Moberg Pharma
Alternative Names: BUPI; BUPI-25; BupizengeLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Oracain
- Developer Hvidovre Hospital; Moberg Pharma
- Class Analgesics; Anilides; Anti-inflammatories; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Piperidines; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Dental pain; Inflammatory pain